WHO adds an HPV vaccine for single-dose use
By Staff Reporter WHO announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine product, Cecolin® has been confirmed for use in a single-dose schedule. The decision is made based on new data on the product that fulfilled the criteria set out in the WHO’s 2022 recommendations for alternative, off-label use of HPV vaccines in single-dose
Read More
Zimbabwe’s HPV Vaccination Coverage Nosedives
By Kudakwashe Pembere The Human Papillomavirus (HPV) vaccination coverage is failing to recover from the harsh effects of the COVID-19 era with data showing that the country is off-trail and coverage has plummeted to record low levels. Health and Child Care Minister Dr Douglas Mombeshora told this publication on the side-lines of the World Health Day
Read MoreZimbabwe’s HPV Vaccination Coverage Nosedives
By Kudakwashe Pembere The Human Papillomavirus (HPV) vaccination coverage is failing to recover from the harsh effects of the COVID-19 era with data showing that the country is off-trail and coverage has plummeted to record low levels. Health and Child Care Minister Dr Douglas Mombeshora told this publication on the side-lines of the World Health
Read More